Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial by Roland Schmitt, Sebastian Häckl, Armin Koch, Elisabeth Bahlmann-Kroll, Stefanie Kramer, Vera Christine Wulfmeyer, Julian Glandorf, Jessica Kaufeld, Dagmar Hartung, Bernhard M W Schmidt, Kai Schmidt-Ott

Get full text